SINGLE DOMAIN ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN

Therapeutic antibodies against ROR-1 protein and methods for use of same

DUAL-AFFINITY PROBES FOR ANALYTE DETECTION

COORDINATED COEXPRESSION OF THROMBIN

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Anti-PCSK9 antibodies

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

PLASMA KALLIKREIN BINDING PROTEINS

ANTIBODIES SPECIFIC FOR ALPHA-1,6-CORE-FUCOSYLATED PSA AND FUCOSYLATED FRAGMENTS THEREOF

OPTIMIZED ANTIBODIES THAT TARGET CD19

COMPOSITIONS AND METHODS FOR TREATING CANCER

METHODS, THERAPIES AND USES FOR TREATING CANCER

Antibodies Directed Against CD127

ANTI-CD28 X ANTI-MSLN ANTIBODIES

COMPOSITION OF TRIAX ANTIBODIES AND METHOD OF MAKING AND USING THEREOF

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

ANTI-SIRPA ANTIBODIES AND METHODS OF USE

ANTIBODY FRAGMENT AGAINST FOLR1

ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF

Antigen binding molecule formats

IL-21 polypeptides and targeted constructs

Tau Immunotherapy

Misfolded TDP-43 Binding Molecules

Human Anti-VEGFR-2/KDR Antibodies

Immune complex

Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias

ANTITUMOR IMMUNE CHECKPOINT REGULATOR ANTAGONISTS

ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF

Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy

Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies

ANTI-CLDN18.2 ANTIBODIES AND DIAGNOSTIC USES THEREOF

SINGLE-DOMAIN ANTIBODIES THAT BIND SARS-COV-2

SHARK-DERIVED BINDING MOLECULES FOR SARS-COV-2 CORONAVIRUS AND USES THEREOF

SARS-COV-2 spike protein binding molecule and application thereof

HSV gE ANTIBODIES

IL-2R-BETA-GAMMA BINDING COMPOUNDS

COMPLEMENT FACTOR BASED AFFINITY CHROMATOGRAPHY

DESIGNED ANTIBODY-BOUND NANOPARTICLES

Anti-Notch2 Antibodies and Conjugates and Methods of Use

INERT FORMAT

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

IL10 receptor binding molecules and methods of use

EGFR x CD28 MULTISPECIFIC ANTIBODIES

Anti-CD3 antibodies and uses thereof

Humanized Anti-TDP-43 Binding Molecules and Uses Thereof

ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF

T CELL RECEPTORS

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Dickkopf-1 variant antibodies and methods of use

ENGINEERED PD-1 ANTIBODIES AND USES THEREOF

CD38 antibodies for the treatment of human diseases

Nucleic acids encoding, and methods of producing, antibodies that bind human chemokine (C—C motif) receptor 8 (CCR8)

HUMANIZED ANTIBODY TARGETING THE TUMOR ASSOCIATED ANTIGEN IL13RA2

Compositions and methods comprising anti-NRP2 antibodies

SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

AGGRECAN BINDING IMMUNOGLOBULINS

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

Antibodies and methods for making and using the same

ANTI-TRKA ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF

PD-L1 BINDING AGENTS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8

Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody

Anti-Notch2 Antibodies and Methods of Use

A CD25-BIASED ANTI-IL-2 ANTIBODY

SUBCUTANEOUS (SC) ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF COMPLEMENT-ASSOCIATED CONDITIONS

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

Ebola Virus Antibodies and Binding Agents Derived Therefrom

NANOFLOWER IMMUNOCHROMATOGRAPHIC STRIP FOR DETECTING HEAVY METAL MERCURY IONS AND USE THEREOF

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

DPP3 BINDER DIRECTED TO AND BINDING TO SPECIFIC DPP3-EPITOPES AND ITS USE IN THE PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS THAT ARE ASSOCIATED WITH OXIDATIVE STRESS

MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT

MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES

BINDING AGENTS BINDING TO EPCAM AND CD137

Chimeric polypeptide assembly and methods of making and using the same

ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF

ANTI C-MET ANTIBODIES

CD3 T-Cell Engagers and Methods of Use

ANTAGONISTIC BIPARATOPIC ANTIBODIES THAT SPECIFICALLY BIND FIBROBLAST GROWTH FACTOR RECEPTOR 2 AND METHODS OF USING SAME

ANTIBODIES SPECIFIC TO DELTA 1 CHAIN OF T CELL RECEPTOR

HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER

BINDING MOLECULES AGAINST FRa

Humanized monoclonal advanced glycation end-product antibody

CHECKPOINT REGULATOR ANTAGONISTS

HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS

Anti-coagulation factor XI antibodies

ANTI-HER2/PD1 BISPECIFIC ANTIBODY

CD37-BINDING MOLECULES IMMUNOCONJUGATES THEREOF

ANTIGEN-BINDING PROTEINS TARGETING KKLC-1 SHARED ANTIGEN

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF

ANTI-TREM2 ANTIBODIES AND RELATED METHODS

VEGF and TIE2-Binding Fusion Protein and Uses Thereof

Production of biosimilar ustekinumab in CHO cells

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

HUMANIZED ANTI-EMAP II THERAPEUTIC ANTIBODIES

USE OF SARS-CoV-2 RECEPTOR BINDING MOTIF (RBM)-REACTIVE MONOCLONAL ANTIBODIES TO TREAT COVID-19

BINDING AGENTS FOR CORONAVIRUS S PROTEIN

PD-1 mutant polypeptide and preparation and application thereof

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

DUAL TARGETING

ANTI-TETRODOTOXIN ANTIBODY Y126C, AND PREPARATION METHOD AND USE THEREOF

Anti-CD73 antibodies and use thereof

ANTI-IL2 RECEPTOR GAMMA ANTIGEN-BINDING PROTEINS

ANTI-CCR8 ANTIBODIES

HUMANIZED ANTI-IL-4Ra SINGLE DOMAIN ANTIBODY AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

ANTIBODIES TARGETING EGFR AND USE THEREOF

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

THERAPEUTIC SIRP-ALPHA ANTIBODIES

Antigen Binding Proteins

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE

Anti-TNF-alpha-antibodies and functional fragments thereof

HUMANIZED ANTI-C5A ANTIBODIES

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

Broadly-Neutralizing HIV Antibodies

ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF

ANTI-GLYCOPROTEIN D ANTIBODIES, METHODS OF PREPARATION, AND USES THEREOF

MDR immunogen

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

ANTIBODY CONSTRUCTS FOR FLT3 AND CD3

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof

ANTI-LAG-3 ANTIBODIES

STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL ANTIBODY

FORMULATIONS OF CD38 ANTIBODIES AND USES THEREOF

METHODS, SYSTEMS, AND KITS FOR TREATMENT OF INFLAMMATORY DISEASES TARGETING TL1A

THERAPEUTIC ANTIBODIES

IL10Ra/IL2Ry SYNTHETIC CYTOKINES

IL2RB/IL2RG SYNTHETIC CYTOKINES

IL10RA binding molecules and methods of use

IL2RB binding molecules and methods of use

IL2RG binding molecules and methods of use

SERUM HALF-LIFE EXTENDED PD-L1 INHIBITORY POLYPEPTIDES

Monoclonal Antibodies to Programmed Death 1 (PD-1)

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

CD3 BINDING ANTIBODIES

Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules

Anti-TNF-alpha-antibodies and functional fragments thereof

Anti-Angiopoietin-2 Antibodies and Uses Thereof

AFFINITY MATURED ANTI-LAP ANTIBODIES AND USES THEREOF

ANTI-MUTANT CALRETICULIN (CALR) ANTIBODIES AND USES THEREOF

BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2)

BINDING PROTEINS RECOGNIZING HPV16 E7 ANTIGEN AND USES THEREOF

HIV-1 ANTIBODIES

Muscle targeting complexes and uses thereof for treating dystrophinopathies

MODIFIED ANTIBODIES

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

Animal Models and Therapeutic Molecules

MULTISPECIFIC SARS-COV-2 ANTIBODIES AND METHODS OF USE

Anti-TMPRSS2 antibodies and antigen-binding fragments

ANTIBODIES AGAINST CDCP1 FOR THE TREATMENT AND DETECTION OF CANCER

ANTIBODIES TO CD70

NEUROPILIN-1 VARIANT ANTIBODIES AND METHODS OF USE

TARGET-RECOGNITION OF ANTIGEN-MHC COMPLEX REPORTER (TRACER) PLATFORM

ANTI-CTLA-4 BINDING PROTEINS AND METHODS OF USE THEREOF

HIV specific binding molecules

Anti-PD-1 Antibodies

ANTI-TIGIT ANTIBODY AND METHODS OF USE THEREOF

ANTI-CD22 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS

ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF

Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia

Modified immunoglobulins for targeting amyloid deposits

Humanized anti-Tau(PS422) antibodies and methods of use

HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413

Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2

IL-10 MUTEINS AND FUSION PROTEINS THEREOF

Anti-Her2 nanobody and coding sequence and use thereof

Animal Models and Therapeutic Molecules

CATABODIES AND METHODS OF USE THEREOF

PROTEINS BINDING NKG2D, CD16 AND EGFR

Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereof

COMPOUNDS AND METHODS TARGETING HUMAN AND MOUSE INSL5

ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

BISPECIFIC SARS-COV-2 ANTIBODIES AND METHODS OF USE

COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT

Anti-transferrin receptor antibody and uses thereof

ANTIBODIES TO FIBROBLAST ACTIVATION PROTEIN AND B7H3

Humanized antibodies against PSMA

Humanized Anti-GPC-1 Antibody

ANTAGONIST ANTI-NPR1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-HUMAN CLAUDIN 18.2 ANTIBODY AND APPLICATION THEREOF

Anti-sclerostin antibodies and methods of use

ANTIBODIES RECOGNIZING TAU

Anti-spike glycoprotein antibodies and the therapeutic use thereof

ANTIBODIES FOR CORONAVIRUS AND USES THEREOF

ACE2-FC FUSION PROTEINS AND METHODS OF USE

MULTISPECIFIC BINDING PROTEINS AND METHODS OF DEVELOPING THE SAME

Antibody that binds ErbB-2 and ErbB-3

Anti-trop2 Antibody

ANTI-OX40 ANTIBODY AND USES THEREOF

TMEM219 ANTIBODIES AND THERAPEUTIC USES THEREOF

ANTI-SIRPg Compounds

Treating refractory migraine

TRANSGENIC PLANTS EXPRESSING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY (VHH) THAT BINDS TO A SPHINGOLIPID OF A FUNGUS

HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2)

IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF

Anti-EDB antibodies and antibody-drug conjugates

SPR-based dual-binding assay for the functional analysis of multispecific molecules

HUMANIZED ANTIBODIES AGAINST LEWIS Y

ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER

Binding Members to PD-L1

ANTI-PD1 ANTIBODIES AND USES THEREOF

CONDITIONALLY ACTIVE ANTI-NECTIN-4 ANTIBODIES

HUMANIZED CD19 ANTIBODY AND USE THEREOF

ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF

METHODS OF TREATING THYROID EYE DISEASE AND GRAVES' ORBITOPAHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS

ANTI-IL-36 ANTIBODIES AND METHODS OF USE THEREOF

IL-5 BINDING MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF

INTERLEUKIN-17 (IL-17) ANTAGONISTIC ANTIBODIES

Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

NANOBODIES DIRECTED TO CORONAVIRUS SPIKE PROTEIN RECEPTOR BINDING DOMAIN AND USES THEREOF

Fusion molecules of CTLA4 and IL-15

GENE THERAPY CONSTRUCTS AND METHODS OF USE

ANTIBODY-BOUND NANOPARTICLES

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

Method for improving affinity of antibody for antigen and use thereof

Method for improving affinity of antibody for antigen and use thereof

Muscle-targeting complex comprising an anti-transferrin receptor antibody linked to an oligonucleotide

MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

MATERIALS AND METHODS OF IL-1BETA BINDING PROTEINS

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

Anti-alpha-synuclein antibodies and uses thereof

METHODS AND COMPOSITIONS RELATED TO NEUTRALIZING ANTIBODIES AGAINST HUMAN CORONAVIRUS

BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION

Animal Models and Therapeutic Molecules

ANTIBODIES FOR BINDING PLASMIN

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

ANTIBODIES TARGETING 5T4 AND USES THEREOF

CD25 antibodies

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

Multispecific antibodies, compositions comprising the same, and vectors and uses thereof

ANTI-ST2 ANTIBODY AND APPLICATION THEREOF

SELECTIVE MODULATION OF TRANSFORMING GROWTH FACTOR BETA SUPERFAMILY SIGNALING VIA MULTI-SPECIFIC ANTIBODIES

Antibodies Targeting CLEC12A and Use Thereof

ANTIBODIES WITH MODIFIED AFFINITY TO FCRN THAT PROMOTE ANTIGEN CLEARANCE

ANTI-PD-1/CD40 BISPECIFIC ANTIBODIES AND USES THEREOF

BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS

FABS-IN-TANDEM IMMUNOGLOBULIN AND USES THEREOF

ANTI-TRANSFERRIN EXTRACELLULAR VESICLES

ANTIBODY SPECIFICALLY BINDING TO GRP94 OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USES THEREOF

ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE

ANTI-SARS-CoV-2 ANTIBODIES AND USES THEREOF

IGA ANTIBODY SPECIFICALLY RECOGNIZING RBD PROTEIN AND TESTING KIT

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

Peptide Therapeutics Against SARS-COV-2 Spike Protein

DIAGNOSTIC ASSAYS AND KITS FOR DETECTION OF FOLATE RECEPTOR 1

DPP3 IN PATIENTS INFECTED WITH CORONAVIRUS

Human Streptococcus Pneumoniae Antibodies and Uses Therefor

METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF

PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS

TRISPECIFIC ANTIBODIES SPECIFIC FOR HER2 AND A BLOOD BRAIN BARRIER RECEPTOR AND METHODS OF USE

ERIBULIN ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

Antibodies binding TNFR2 and uses thereof

HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES

BISPECIFIC FC MOLECULES

PD-1 AGONIST MULTIMERIC BINDING MOLECULES

COMPLEMENTARITY-DETERMINING REGIONS FOR BINDING CD3, AND BISPECIFIC ANTIGEN-BINDING MOLECULE CONTAINING SAID CDRS

C-KIT antibodies and method for treating cancer with such

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR ANTI-PACAP ANTIBODIES

ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOF

COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME

Antibody neutralizing human respiratory syncytial virus

Filovirus antibodies and methods

CYSTEINE LINKED NANOBODY DIMERS

METHOD FOR PRODUCING ANTIBODY

RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE

ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

ANTI-VWF D'D3 SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF

ANTI-SIRP-ALPHA ANTIBODIES

Anti-CD38 binding domains

Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

Anti-human interleukin-4 receptor alpha antibody and preparation method and application thereof

Anti-CSF1R Molecules and Use Thereof

ANTI-PD-L1 AND PD-L2 ANTIBODY AND DERIVATIVES AND USE THEREOF

Chimeric antigen receptors targeting GPRC5D

NOVEL ANTI-CD3EPSILON ANTIBODIES

BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

Engineered anti-IL-2 antibodies

ANG2-BINDING MOLECULES

TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A NOVEL CIRCULATING HORMONE COMPLEX

POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2, GENERATION AND USES THEREOF

ANTI-YELLOW FEVER VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

METHODS AND COMPOSITIONS RELATING TO CHIMERIC ANTIGEN RECEPTORS

ANTI-PD-L1 ANTIBODIES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY